Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Cadila Health
Cadila Health
BSE: 532321NSE: CADILAHCISIN: INE010B01027

2nd-Oct-2019 09:53Source: BSE

Cadila Healthcare - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus announces positive results from EVIDENCES IV Phase 2 clinical trial of Saroglitazar Magnesium in NAFLD and NASH

Board Meeting (Cadila Health)

Meeting Date

Remark

2019-11-13

Quarterly Results

Sections
Follow us on
Available On